MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ehf2.15327

Медицинская библиотека · ESC heart failure · 2025

Quality of life after transcatheter tricuspid valve repair: results from the Tri.FR trial.

Istratoaie Sabina, de Groote Pascal, Karam Nicole, Trochu Jean-Noel, Leurent Guillaume, Coisne Augustin, Le Roux Pierre-Yves, Ganivet Anne, Bernard Anne, Neylon Antoinette, Pierrard Romain, Le Ven Florent, Picard François, Piriou Nicolas, Laperche Thierry, Jouan Jerome, Anselmi Amedeo, Auffret Vincent, Oger Emmanuel, Donal Erwan

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

AIMS: In the Tri.FR trial, tricuspid transcatheter edge-to-edge repair (T-TEER) reduced severity of tricuspid regurgitation (TR) and improved the composite clinical score, driven by patient-reported outcomes. The purpose of this study was to describe the longitudinal impact of T-TEER on different dimensions and items of quality of life compared with guideline-directed medical treatment (OMT) alone.

METHODS AND

RESULTS

Patients were randomized to T-TEER +OMT (n = 152) or OMT alone (n = 148). Health status was assessed at baseline, 6 weeks, 6 months, and 1 year using the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Minnesota Living with Heart Failure (MLHF) Questionnaire. Mixed effects linear regression analysed changes over time. Patients receiving T-TEER + OMT experienced a significant increase in KCCQ overall summary score (KCCQ-OS) at all time points: +17.0 points (95% confidence interval [CI] 13.1-21.5) at 6 weeks, +15.9 points (95% CI 11.2-20.6) at 6 months, and +18.7 points (95% CI 13.8-23.6) at 1 year. The mean between-group difference in KCCQ-OS was +10.3 points (95% CI 5.6-15.0) in favour of T-TEER + OMT, evident at 6 weeks and sustained for 1 year. Similarly, MLHF total scores improved significantly in the T-TEER group (mean between-group difference -8.61 points, 95% CI -12.6 to -4.6), including physical (-3.9, 95% CI -5.9 to -1.9) and emotional (-2.2, 95% CI -3.4 to -1.0) subscales.

CONCLUSIONS

Compared with OMT alone, T-TEER resulted in substantial, multidimensional, and sustained improvements in patient-reported quality of life. These findings reinforce the value of T-TEER in managing severe symptomatic TR.

Для цитирования: Istratoaie Sabina, de Groote Pascal, Karam Nicole, Trochu Jean-Noel, Leurent Guillaume, Coisne Augustin, Le Roux Pierre-Yves, Ganivet Anne, Bernard Anne, Neylon Antoinette, Pierrard Romain, Le Ven Florent, Picard François, Piriou Nicolas, Laperche Thierry, Jouan Jerome, Anselmi Amedeo, Auffret Vincent, Oger Emmanuel, Donal Erwan. Quality of life after transcatheter tricuspid valve repair: results from the Tri.FR trial.. ESC heart failure. 2025. DOI: 10.1002/ehf2.15327.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.